The current dogma states that there are two pathways of intestinal Ca 2+ absorption [1]. The first is the facilitated diffusion pathway. It is a secondary active, transcellular process with entry into enterocytes occurring through TRPV6 in the apical membrane. Entry is driven by the electrochemical gradient, The transcellular component is saturable, whereas the paracellular component is non-saturable (linear).
The second pathway of intestinal Ca 2+ absorption is paracellular flow through tight junctions [2] . It is often described as vitamin D-independent and driven by a downhill gradient of Ca 2+ and solvent drag.
The transcellular component is saturable, whereas the paracellular component is non-saturable (linear).
The TRPV6 transcellular pathway is predominant in duodenum, but the paracellular pathway is predominant in jejunum and the only component in ileum. Because the transit times for chyme through jejunum and ileum are much longer than that through duodenum, the current view is that 80% of absorption occurs by paracellular flow.
The dogma of transcellular absorption has been brought into question by studies on genetically modified mice. Of note, single knockouts for either TRPV6 or calbindin-D 9K have no effect on Ca 2+ homeostasis or absorption. Even more startling is the observation that Ca 2+ absorption in TRPV6/calbindin-D 9K double knockout mice is still some 50-60% of control. As noted, the findings challenge "the dogma of the need for TRPV6 and calbindin-D9K for 1,25(OH) 2 D 3 -induced calcium absorption [3] ."
What has not previously been appreciated is that knockout studies question the very basis of the argument for paracellular flow. Thus, assignment of the linear component to paracellular absorption was made on the basis that ileum does not contain calbindin-D 9K , which, in the dogma, is essential for th EITG Conference 
Ca v 1.3 is present in the apical membrane of small intestine
We discovered Ca v 1.3 while working on jejunal glucose absorption. There are two pathways of glucose absorption, one through SGLT1 and the other the facilitative glucose transporter GLUT2 [4] .
They can be readily resolved by the inhibitors, phloridzin and phloretin, respectively. Transport of glucose through SGLT1 induces rapid trafficking of GLUT2 to the apical membrane, so that at glucose concentrations between 30-100 mM, much higher than the 30 mM required to saturate SGLT1, the flux through apical GLUT2 becomes several-fold greater than through SGLT1. As glucose concentration decreases with absorption, so GLUT2 traffics back to sub-apical membrane vesicles. The process requires two signals. The first must be entry of Ca
2+
, because GLUT2 insertion is dependent on PKC II and cytoskeletal rearrangement. The second is provided by sweet taste receptors, since the artificial sweetener sucralose doubles glucose absorption by doubling apical GLUT2 without effect on SGLT1 [4] .
The immediate question is how Ca 2+ enters the enterocyte to stimulate apical GLUT2 insertion under highly depolarizing conditions -the dogma provides no satisfactory explanation. Homology-based PCR demonstrated the presence of Ca v 1.3 in jejunal mucosa and Western blotting confirmed its presence in the apical membrane [5] . Crucially immunocytochemistry revealed that Ca v 1.3 was located at highest levels in the heart of the digestive centre from mid-jejunum to mid ileum. There was little in duodenum and caecum, where most previous trials of L-type blockers had been tested. In rat jejunum perfused in vivo with high glucose, Ca 2+ absorption displayed L-type characteristics. Active absorption of 1.25 mM Ca 2+ was maximal at 20 mM glucose; absorption was inhibited by nifedipine and verapamil and activated with Bay K-8644, which have no effect on TRPV6. Ca v 1.3 is 10-fold less th EITG Conference [7] .
The role of apical membrane potential
Review diagrams of intestinal Ca Introduction: The amiloride-sensitive epithelial sodium channel (ENaC) plays a key role in electrogenic Na + absorption in the colon. Impaired ENaC function, a major factor in the pathogenesis of diarrhea in patients with inflammatory bowel disease (IBD), is improved by glucocorticoids (GCs) via glucocorticoidreceptor (GR)-dependent induction. Aim: To investigated whether STIM1 or Orai1 exist in colonic epithelial cells and whether they exert a functional role.
Methods:
For the experiments we used immunohistochemical techniques, Ussing chamber experiments, and imaging technology with fura-2.
Results: Immunohistochemical investigations revealed the expression of all subtypes of STIM and
Orai in the rat colonic epithelium. Store depetion by incubation in Ca
2+
-free buffer combined with cyclopiazonic acid, led to a translocation of STIM1 not only to the basolateral, but also to the apical membrane of the enterocytes as observed with a confocal microscope. Ussing chamber experiments revealed a functional significance for Ca 2+ influx across both membranes. After store-depletion, repletion of either apical or basolateral Ca 2+ induced a chloride secretion measured as increase in short-circuit current. If basolateral Ca 2+ channels were blocked with lanthanum, this increase in shortcircuit current was completely suppressed. A similar, albeit less pronounced, stimulation of La 3+ -sensitive short-circuit current was observed, when Ca 2+ was restored in the apical medium.
Conclusion:
These data indicate that STIM1 and Orai1 exist in intestinal epithelial cells; they may function as Ca 2+ channel after store-depletion.
